Immunex Team Finds Success By Shifting Its Key Players

The staff at Immunex Corp. likes to joke that no wall in the biotechnology firm's Seattle headquarters has ever stayed in one place for more than a year. Instead, the walls keep getting moved around at this nine-year-old company to make room for more scientists and more labs. Although the staffers are talking about the tangible plaster and wood walls, they might as well be talking about the invisible divisions that normally define scientific teams. At Immunex, those sorts of walls get moved ar

Written byKathryn Phillips
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The staff at Immunex Corp. likes to joke that no wall in the biotechnology firm's Seattle headquarters has ever stayed in one place for more than a year. Instead, the walls keep getting moved around at this nine-year-old company to make room for more scientists and more labs.

Although the staffers are talking about the tangible plaster and wood walls, they might as well be talking about the invisible divisions that normally define scientific teams. At Immunex, those sorts of walls get moved around all the time, too.

The boundaries that define research teams at the firm are just about as fluid as they can get, says biochemist Linda Park. And the resulting cooperation among the scientists is one reason the firm has been so successful - and rapid - in its interleukin research, says Park's colleague Ray Goodwin.

The working environment at Immunex is "not like a university, where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies